Skip to main content
. 2023 Aug 1;5(5):613–624. doi: 10.1016/j.jaccao.2023.05.011

Central Illustration.

Central Illustration

Systematic Review of Randomized Controlled Trials Evaluating Gonadotropin-Releasing Hormone Antagonists vs Agonists

Included randomized controlled trials evaluating gonadotropin-releasing hormone (GnRH) antagonists and agonists among patients with prostate cancer. Forest plot of odds ratios comparing GnRH antagonists vs agonists for major adverse cardiovascular events (MACEs). CrI = credible interval; RR = relative risk.